跳至主要内容
临床试验/JPRN-jRCT1080222457
JPRN-jRCT1080222457未知Unknown

Freeze-dried live attenuated measles and rubella combined vaccine Takeda Specified drug-use survey of vaccinees after the second vaccination

TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 3,000 人开始时间: 2014年4月9日最近更新:
适应症

试验速览

阶段
Unknown
发起方
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Vaccinees who meet both of the following conditions [1] and [2]:
  • [1] Vaccinees who have a prior history of receiving measles and/or rubella vaccination and who received freeze-dried live attenuated measles and rubella combined vaccine Takeda as the second vaccination
  • [2] Vaccinees whose guardians are able to participate in a questionnaire survey on the health status of vaccinees after vaccination with freeze-dried live attenuated measles and rubella combined vaccine Takeda

排除标准

  • 未提供

研究者

发起方
TAKEDA PHARMACEUTICAL COMPANY LTD.

相似试验